Visit Shenzhen Qianhai Taikang Hospital in Shenzhen to jointly promote the application of cell therapy technology in Qianhai Free Trade Zone
On April 1, 2025, under the coordination of Shenzhen Municipal Committee of the Communist Youth League and Shenzhen Youth Science and Technology Association, two vice-chairman units of the association——— Shenzhen Cell Valley and Shenzhen Qianhai Taikang Hospital—held a cooperation symposium. The two parties conducted in-depth discussions on collaborating in health management through stem cell and exosome technologies. This partnership aims to integrate premium medical resources with cutting-edge biotechnology, providing innovative anti-aging and health management services for high-net-worth individuals, while jointly driving innovation and development in the Greater Bay Area's healthcare industry.
At the opening of the conference, Zhang Yuxiao, Senior Medical Director of Taikang Healthcare's Qianhai Hospital in Shenzhen, outlined the hospital's development strategy and highlighted the distinctive services offered by its International Medical Department. Leveraging its strengths in oncology treatment and anti-aging research, the hospital is committed to establishing a premium health management platform, aiming to introduce cell therapy technologies for high-net-worth clients to deliver cutting-edge wellness solutions. Li Xianxin, Vice President of Qianhai Hospital, emphasized that as a strategic foothold for Taikang Healthcare in South China, the hospital consistently drives medical service upgrades through technological innovation, striving to build an innovative ecosystem integrating "insurance, healthcare, and health management." The International Medical Department will focus on addressing health management needs for sub-healthy populations, utilizing Taikang Insurance's extensive client network to provide premium wellness solutions. He stressed: "Safety and compliance remain our top priorities. This collaboration will enable the hospital to leverage cell therapy's technological advantages in oncology treatment and anti-aging research."
Shi Yuanyuan, Chairman of Shenzhen Cell Valley, elaborated on the company's technological advantages and quality control systems in stem cells, NK cells, and exosomes. He stated that Shenzhen Cell Valley will leverage its R&D strengths to collaborate with Taikang Shenzhen Hospital in exploring compliant application pathways for cell therapy technologies in health management, providing consumers with safe and effective health services. The company will also establish a comprehensive service record system to ensure traceability and mitigate potential legal and public opinion risks. Shi noted that they could draw on policy experiences from Hainan Boao Lecheng International Medical Tourism Pilot Zone to explore compliant approaches for stem cell clinical research. Through Shenzhen Cell Valley Group's international operations and its medical service headquarters —— Shenzhen-Hong Kong Cell Valley (Shenzhen) Medical Technology Co., Ltd. located in Qianhai, the company will actively seek policy support from Qianhai Free Trade Zone for cell therapy, driving innovative development of the Greater Bay Area's cell therapy industry.
The attendees included Li Xiaoxia, Second-Level Researcher at the United Front and Liaison Department of Shenzhen Municipal Committee of the Communist Youth League; Yu Yuanzhi, Secretary-General of Shenzhen Young Scientists Association; Lü Zhuoyuan, General Manager of Marketing Planning Department and Market Director of Qianhai Taikang Hospital in Shenzhen; Zhu Da, Office Director of Medical Service Management Department at Health Service Center; Li Chengliang, Deputy Chief Physician of General Practice at Senior Medical Center; Xuan Fanxin, Head Nurse at Senior Medical Center; Chen Xinyi, Secretary to the Director of Senior Medical Center; Tang Xiaomeng, General Manager of Shenzhen-Hong Kong Cell Valley and Deputy General Manager of Shenzhen Cell Valley; Tang Hui, Business Director of Shenzhen Cell Valley; and Wei Zheng, Head of Administrative Department at Shenzhen Cell Valley.
The attendees included Li Xiaoxia, Second-Level Researcher at the United Front and Liaison Department of Shenzhen Municipal Committee of the Communist Youth League; Yu Yuanzhi, Secretary-General of Shenzhen Young Scientists Association; Lü Zhuoyuan, General Manager of Marketing Planning Department and Market Director of Qianhai Taikang Hospital in Shenzhen; Zhu Da, Office Director of Medical Service Management Department at Health Service Center; Li Chengliang, Deputy Chief Physician of General Practice at Senior Medical Center; Xuan Fanxin, Head Nurse at Senior Medical Center; Chen Xinyi, Secretary to the Director of Senior Medical Center; Tang Xiaomeng, General Manager of Shenzhen-Hong Kong Cell Valley and Deputy General Manager of Shenzhen Cell Valley; Tang Hui, Business Director of Shenzhen Cell Valley; and Wei Zheng, Head of Administrative Department at Shenzhen Cell Valley.
